Ignite Creation Date:
2024-05-05 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00344773
Status:
COMPLETED
Last Update Posted:
2010-06-29
First Post:
2006-06-26
Brief Title:
First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor EGFR Mutation
Sponsor:
AstraZeneca
Organization:
AstraZeneca